Pulling SEC filings + quote and writing the call…

SONIDA SENIOR LIVING, INC.
Next earnings Aug 10, 2026 · consensus $-1.18 EPS, $214M rev
Last earnings -3.4% on 2026-05-11
Leveraged senior-living roll-up with wiped-out equity and a $1.8B debt-funded merger; price runs far above insiders' own $26.74 mark.
Price $39.67 · current
Sonida is growing the top line fast (FY2025 revenue $381M, +25.2%) but the quality beneath that growth is poor. The company has lost money every year since FY2022, and FY2025 net loss widened to -$70.8M (diluted EPS -$4.22) from -$2.06M the prior year. The 10-K reconciliation shows the loss is driven by D&A of $56.8M, $12.5M of long-lived asset impairment, $16.2M of transaction/restructuring costs and $38.6M of interest expense — and was only cushioned by a one-time $48.5M gain on extinguishment of debt. Strip the gain out and core operations are deeply unprofitable on a GAAP basis. Operating cash flow did turn positive at $24.4M, but that is swamped by $33.3M of capex, so the business does not self-fund its real-estate reinvestment.
The balance sheet is the central problem. Stockholders' equity has been reduced to essentially zero (-$11.0K) against $789M of liabilities and an accumulated deficit of -$491M; long-term debt is $682M and cash is just $11M, down 35%. Working capital is negative ($77.9M current assets vs $105M current liabilities). Shares outstanding jumped +150.5% to 47.4M, so existing holders have been heavily diluted. This is a thinly-capitalized, highly-levered operator with no equity cushion to absorb a downturn.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 1:03 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $235M | $238M | $255M | $304M | $381M |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | $57.9M | $68.7M | — |
| Net income | $126M | -$54.4M | -$21.1M | -$2.06M | -$70.8M |
| Diluted EPS | $37.92 | -$9.27 | -$3.85 | -$0.54 | -$4.22 |
| Net margin | 53.5% | -22.8% | -8.3% | -0.7% | -18.6% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting voting results filed; routine director/governance votes ratified
Officer/director change plus Reg FD investor disclosure post-CHP merger
Amended 8-K, likely CHP pro forma financials for the $1.8B acquisition
Amended 8-K, likely CHP pro forma financials for the $1.8B acquisition
Terminated a material agreement; other-events update on debt/operations
Q1'26 10-Q: CHP merger doubles portfolio but debt load and losses persist
Q1'26 10-Q: CHP merger doubles portfolio but debt load and losses persist
Annual proxy: director slate, exec pay, post-merger governance items
Officer/director appointment or departure disclosed
Sources: SEC EDGAR (CIK 0001043000, latest 10-Q filed 2026-05-11) · EODHD · Proprietary analysis · as of 6/30/2026, 5:03:01 AM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 1 sale
| 2026-06-11 | Harris Benjamin P Director | Award | 7.12K | |
| 2026-06-11 | Mauldin Stephen H Director | Award | 4.13K | |
| 2026-06-11 | Donohue Lilly Director | Award | 4.13K | |
| 2026-06-11 | KRUEGER JILL M Director | Award | 4.13K | |
| 2026-06-11 | Martin J Chandler Director | Award | 4.13K | |
| 2026-06-11 | Levinson Sam Director | Award | 6.41K | |
| 2026-06-02 | Levy Max SVP & Chief Investment Officer | Tax | 1.78K @ $32.75 | $58.5K |
| 2026-05-13 | Harris Benjamin P Director | Sell | 2.50K @ $37.46 | $93.7K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1 sell · 1 member · last 180d
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.